Drreddys Laboratories | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
ANI Pharmaceuticals USD 418.62M 14.94M 2025-03
Aurora Cannabis CAD 572.92M 29.75M 2024-12
Bayer EUR 32.58B 537M 2025-03
Canopy Growth CAD 591.48M 81.81M 2024-12
Cipla INR 311.93B 27.38B 2025-03
Corcept Therapeutics USD 683.28M 3.7M 2025-03
Drreddys Laboratories INR 317.72B 12.38B 2024-12
GlaxoSmithKline GBP 14.16B 486M 2025-03
Hikma Pharmaceutical USD 2.29B 88M 2024-06
Lonza CHF 9.33B 23M 2024-12
Novartis USD 44.05B 605M 2024-12
Pacira USD 798.54M 20.19M 2025-03
Prestige Brands USD 1.83B 46.46M 2025-03
Richter Gedeon HUF 1.3T 76.1B 2024-12
Sun Pharmaceuticals INR 722.18B 28.38B 2025-03
Supernus Pharmaceuticals USD 1.04B 28.58M 2024-12
Teva Pharmaceutical Industries USD 6.26B 542M 2025-03



Drreddys Laboratories Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.